MEI Pharma, Inc.

11455 El Camino Real, Suite 250
San Diego
United States

Tel: (858) 369-7100


Show jobs for this employer

About MEI Pharma, Inc.

MEI Pharma is clinical-stage pharmaceutical company committed to the development and commercialization of novel, best-in-class, cancer therapies intended to improve outcomes for patients. Our approach is to fully understand and leverage the mechanisms and properties of our drug candidates to optimize the balance between efficacy and tolerability to best meet the needs of patients with cancer.


MEI Pharma's portfolio of drug candidates includes multiple clinical-stage assets, including zandelisib, currently in ongoing clinical studies intended to support marketing applications with the U.S. Food and Drug Administration and other regulatory authorities globally. Each of MEI Pharma's pipeline candidates has a unique mechanism of action that can target pathways involved in driving various hematological malignancies and/or solid tumors that we believe: (1) have the potential to be best-in-class, (2) address unmet medical needs and (3) deliver improved outcomes to patients either as standalone treatments or in combination with other therapeutic options. MEI is headquartered in San Diego, CA.

Stock Symbol:


345 articles with MEI Pharma, Inc.